by Robert Malone MD MS, Who Is Robert Malone:

A bit of knowledge about “public health” can be a dangerous thing when financially conflicted partisans control the executive branch.

Last February, the serving White House (WH) Chief of Staff (COS) quietly resigned, and a new one was ushered in. But a comparison of the outgoing and incoming WH Chief of Staff demonstrates striking similarities. A careful reading of the bios of Biden’s two chief of staff picks reveals a disturbing trend. Both choices appear consistent with – first and foremost – the capture of both the “health”-related administrative state and the levers of the Biden administration itself by the pharmaceutical-medical industrial complex.